BENNETT C FRANK
EVP, Chief Scientific Officer
BENNETT C FRANK has filed 9 SEC Form 4 filings (24 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Jul 9, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$19.4M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| IONS | EVP, Chief Scientific Officer | Sale | 20,536 | $1.7M | Jul 9 | SEC ↗ | |
| IONS | EVP, Chief Scientific Officer | Sale | 85,089 | $6.7M | Mar 5 | SEC ↗ | |
| IONS | EVP, Chief Scientific Officer | Sale | 85,089 | $7.1M | Feb 4 | SEC ↗ | |
| IONS | EVP, Chief Scientific Officer | Sale | 5,885 | $488K | Feb 2 | SEC ↗ | |
| IONS | EVP, Chief Scientific Officer | Sale | 8,977 | $675K | Jan 20 | SEC ↗ | |
| IONS | EVP, Chief Scientific Officer | Sale | 6,000 | $358K | Sep 9 | SEC ↗ | |
| IONS | EVP, Chief Scientific Officer | Sale | 5,000 | $246K | Sep 4 | SEC ↗ | |
| IONS | EVP, Chief Scientific Officer | Sale | 33,909 | $2.1M | Sep 4 | SEC ↗ |